The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement
Abstract
DESCRIPTION: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults. METHODS: The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes in asymptomatic, nonpregnant adults who are at average or high risk for diabetes and its complications. POPULATION: This recommendation applies to adults aged 40 to 70 years seen in primary care settings who do not have symptoms of diabetes and are overweight or obese. RECOMMENDATION: The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. (B recommendation).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intensive Behavioral Counseling (IBC) interventions like the National Diabetes Prevention Program (NDPP), have demonstrated effectiveness in reducing excess body weight and lowering or delaying morbidity onset.”
In the citing paper
“Intensive Behavioral Counseling (IBC) has been widely accepted as an effective approach for compliant individuals to reduce body weight, improve clinical measures, and lower risk of obesity-related comorbidities [1–6].”
In the citing paper
“The US Preventive Services Task Force (USPSTF) recommends that, as part of cardiovascular diseases (CVD) risk assessment, all overweight and obese adults between age 40 and 70 be screened for abnormal blood glucose, and those with CVD risk factors (e.g., hypertension, dyslipidemia, prediabetes) be referred for IBC, such as programs modeled on the National Diabetes Prevention Program (NDPP) [3,5].”
In the citing paper
“All individuals met the USPSTF criteria for receiving IBC because they had CVD risk factors independent of excess body weight; with 997 (89%) also meeting the CDC and NDPP recommendations for intervention due to prediabetes [3,5,17].”
In the citing paper
“Previous work has found that IBC intervention, including NDPP, among overweight and obese adults with prediabetes and CVD risk factors can improve clinical measures, prevent or delay disease onset, reduce medical expenditures, and increase productivity (in the form of higher labor force participation and lower work absenteeism) [1–6,13–15,19].”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“The Diabetes Prevention Program (11), conducted in the United States in 3234 participants, found that an intensive lifestyle modification intervention was associated with better quality of life at 3-year follow-up.”
BackgroundStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“Similarly, the Steno-2 Study (31) showed a reduction in all-cause mortality (RR, 0.”
BackgroundEffects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600 · cited 3×
“One Finnish (12) and 1 Chinese (13) trial, each with more than 500 participants, suggested improvements in all-cause mortality outcomes after 10 and 20 years, respectively (HR, 0.”
BackgroundInfluential
Research works printed but not linked: 3
- Mortaz S, 2012, Clinicoecon Outcomes Res, 4, 91
- Hemmingsen B, 2013, Cochrane Database Syst Rev, 11, CD008143
- American Diabetes Association, 2015, Diabetes Care, 38, S1
Cited by
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Diabetes 2030: Insights from Yesterday, Today, and Future Trends
Rowley, W. R., Bezold, C., Arikan, Y., Byrne, E., & Krohe, S. (2017) · Population Health Management · doi:10.1089/pop.2015.0181 · Cited by 655
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A. R., Gillman, M. W., Kemper, A. R., Krist, A. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.15450 · Cited by 589
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Grossman, D. C., et al. (2018) · JAMA · doi:10.1001/jama.2018.13022 · Cited by 563
Elmets, C. A., Leonardi, C. L., Davis, D. M. R., Gelfand, J. M., Lichten, J., Mehta, N. N., Armstrong, A. W., Connor, C., Cordoro, K. M., Elewski, B. E., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.058 · Cited by 503
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.12531 · Cited by 480
Patnode, C. D., Evans, C. V., Senger, C. A., Redmond, N., & Lin, J. S. (2017) · JAMA · doi:10.1001/jama.2017.3303 · Cited by 380
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.21749 · Cited by 367
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kubik, M., et al. (2020) · JAMA · doi:10.1001/jama.2020.0435 · Cited by 374
Jagannathan, R., Patel, S. A., Ali, M. K., & Narayan, K. M. V. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1161-2 · Cited by 369
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Alam, S., Hasan, M. K., Neaz, S., Hussain, N., Hossain, M. F., & Rahman, T. (2021) · Diabetology · doi:10.3390/diabetology2020004 · Cited by 323
Comorbidity in multiple sclerosis: implications for patient care
Marrie, R. A. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.33 · Cited by 248
Diabetes complications in racial and ethnic minority populations in the USA.
Haw, J. S., Shah, M., Turbow, S., Egeolu, M., & Umpierrez, G. (2021) · Current Diabetes Reports · doi:10.1007/s11892-020-01369-x · Cited by 240
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI
Singh, A., Collins, B. L., Gupta, A., Fatima, A., Qamar, A., Biery, D., Baez, J., Cawley, M., Klein, J., Hainer, J., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.007 · Cited by 212
Ali, M. K., Bullard, K. M., Saydah, S., Imperatore, G., & Gregg, E. W. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30027-5 · Cited by 208
White Paper AGA: POWER — Practice Guide on Obesity and Weight Management, Education, and Resources
Acosta, A., Streett, S., Kroh, M. D., Cheskin, L. J., Saunders, K. H., Kurian, M., Schofield, M., Barlow, S. E., & Aronne, L. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.023 · Cited by 191
“Preventive Services Task Force now recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40–70 years with overweight or obesity.(38) Laboratory testing for specific conditions should be done, depending on the findings on history and physical examination.”
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.8357 · Cited by 162
Diabetes Mellitus: Screening and Diagnosis.
Pippitt, K. A., Li, M., & Gurgle, H. E. (2016) · PubMed · Cited by 221
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 203
Cefalu, W. T., Buse, J. B., Tuomilehto, J. O., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0873 · Cited by 157
Endocrine Late Effects in Childhood Cancer Survivors
Chemaitilly, W., Cohen, L. E., Mostoufi‐Moab, S., Patterson, B. C., Simmons, J. H., Meacham, L. R., van Santen, H. M., & Sklar, C. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.3268 · Cited by 149
“Furthermore, CCSs should be counseled about the benefits of regular physical activity on bone remodeling and the deleterious effects of smoking and alcohol consumption.71 In conclusion, endocrine complications are among the most common late effects in CCSs.”
BackgroundCastro Sweet, C. M., Chiguluri, V., Gumpina, R., Abbott, P., Madero, E. N., Payne, M., Happe, L., Matanich, R., Renda, A., & Prewitt, T. (2018) · Journal of Aging and Health · doi:10.1177/0898264316688791 · Cited by 130
Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M. D., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Kubik, M., et al. (2021) · JAMA · doi:10.1001/jama.2021.11922 · Cited by 169
Effect of Vitamin D Supplementation on the Incidence of Diabetes Mellitus
Barbarawi, M., Zayed, Y., Barbarawi, O., Bala, A., Al‐Abdouh, A., Gakhal, I., Rizk, F., kasasbeh, M. A., Bachuwa, G. I., & Manson, J. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa335 · Cited by 114
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association
Lazar, R. M., Howard, V. J., Kernan, W. N., Aparicio, H. J., Levine, D. A., Viera, A. J., Jordan, L. C., Nyenhuis, D. L., Possin, K. L., Sorond, F. A., et al. (2021) · Stroke · doi:10.1161/str.0000000000000367 · Cited by 109
Gujral, U. P., Vittinghoff, E., Mongraw‐Chaffin, M., Vaidya, D. M., Kandula, N. R., Allison, M., Carr, J. J., Liu, K., Narayan, K. M. V., & Kanaya, A. M. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1895 · Cited by 119
Armenian, S. H., Chemaitilly, W., Chen, M. Y., Chow, E. J., Duncan, C., Jones, L. W., Pulsipher, M. A., Remaley, A. T., Rovó, A., Salooja, N., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.08.019 · Cited by 111
Screening for Diabetes and Prediabetes
Duan, D., Kengne, A. P., & Echouffo-Tcheugui, J. B. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.002 · Cited by 145
Prevention of Cardiovascular Disease
Reamy, B. V., Williams, P. M., & Kuckel, D. P. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.11.003 · Cited by 128
Parcha, V., Heindl, B. F., Kalra, R., Li, P., Gower, B. A., Arora, G., & Arora, P. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab645 · Cited by 127
Screening for Diabetes in Adults
Ékoé, J.-M., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.004 · Cited by 125
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture
Narayan, K. M. V. (2016) · Diabetes Care · doi:10.2337/dc16-0205 · Cited by 96
Kumar, G. S., Beeler, J. A., Seagle, E. E., & Jentes, E. S. (2021) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-021-01146-2 · Cited by 80
Survey of primary care providers’ knowledge of screening for, diagnosing and managing prediabetes
Tseng, E., Greer, R. C., O’Rourke, P., Yeh, H., McGuire, M., Clark, J. M., & Maruthur, N. M. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4103-1 · Cited by 95
All Patients Should Be Screened for Diabetes Before Total Joint Arthroplasty
Shohat, N., Goswami, K., Tarabichi, M., Sterbis, E., Tan, T. L., & Parvizi, J. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.02.047 · Cited by 80
Evidence and challenges for translation and population impact of the Diabetes Prevention Program.
Ackermann, R. T., & O’Brien, M. J. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1293-4 · Cited by 62
Diabetes Among Non-Overweight Individuals: an Emerging Public Health Challenge
Gujral, U. P., Weber, M. B., Staimez, L. R., & Narayan, K. M. V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1017-1 · Cited by 73
Ritchie, N. D., Baucom, K. J., & Sauder, K. A. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s218334 · Cited by 77
Simmons, R. K., Griffin, S. J., Lauritzen, T., & Sandbæk, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4299-y · Cited by 69
“proposed or introduced in a number of countries [8, 9].”
BackgroundChen, F., Su, W., Becker, S. H., Payne, M., Castro Sweet, C. M., Peters, A. L., & Dall, T. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163627 · Cited by 60
“Similar to the NDPP and DPPOS results, the declining percentage reduction in diabetes onset over time (e.g., year 10 versus year 3) reflects that for many people lifestyle changes might delay but not prevent diabetes onset.”
BackgroundMethodInfluentialChow, E. J., Chen, Y., Armstrong, G. T., Baldwin, L., Cai, C., Gibson, T. M., Hudson, M. M., McDonald, A. J., Nathan, P. C., Olgin, J. E., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024735 · Cited by 73
Cardiovascular Risk Assessment: A Systematic Review of Guidelines
Khanji, M. Y., Bicalho, V. V. D. S., van Waardhuizen, C. N., Ferket, B. S., Petersen, S. E., & Hunink, M. G. M. (2016) · Annals of Internal Medicine · doi:10.7326/m16-1110 · Cited by 82
Aging Is a Powerful Risk Factor for Type 2 Diabetes Mellitus Independent of Body Mass Index
Fazeli, P. K., Lee, H., & Steinhauser, M. L. (2019) · Gerontology · doi:10.1159/000501745 · Cited by 63
Prospects for the Primary Prevention of Myocardial Infarction and Stroke
Caldwell, M., Martinez, L. C., Foster, J. G., Sherling, D. H., & Hennekens, C. H. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418817344 · Cited by 77
Perioperative Evaluation and Management of Endocrine Disorders
Himes, C. P., Ganesh, R., Wight, E. C., Simha, V., & Liebow, M. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.004 · Cited by 65
Prevention of Diabetes Mellitus in Patients With Prediabetes
Carris, N. W., Magness, R. R., & Labovitz, A. J. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.10.032 · Cited by 66
Lin, K., Yi, J., Mao, X., Wu, H., Zhang, L., & Yang, L. (2019) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2019.01.016 · Cited by 59
Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention
O’Brien, M. J., Moran, M. R., Tang, J. W., Vargas, M. C., Talen, M. R., Zimmermann, L. J., Ackermann, R. T., & Kandula, N. R. (2016) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716666678 · Cited by 63
“The US Preventive Services Task Force’s recent recommendation for abnormal blood sugar screening will identify many patients with prediabetes who could benefit from treatment to prevent or delay diabetes.(9) Large clinical trials have established that structured, intensive lifestyle interventions (ILIs) and metformin…”
BackgroundMenopause, hormone therapy and diabetes
Stuenkel, C. A. (2017) · Climacteric · doi:10.1080/13697137.2016.1267723 · Cited by 62
Primary Care Providers’ Prediabetes Screening, Testing, and Referral Behaviors
Nhim, K., Khan, T., Gruss, S. M., Wozniak, G., Kirley, K., Schumacher, P., Luman, E. T., & Albright, A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.017 · Cited by 54
Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach
Schelke, M. W., Hackett, K., Chen, J. L., Shih, C., Shum, J., Montgomery, M. E., Chiang, G. C., Berkowitz, C., Seifan, A., Krikorian, R., et al. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13070 · Cited by 51
Gopalan, A., Mishra, P., Alexeeff, S., Blatchins, M. A., Kim, E., Man, A. H., & Grant, R. W. (2018) · Diabetic Medicine · doi:10.1111/dme.13808 · Cited by 60
Simmons, R. K., Griffin, S. J., Witte, D. R., Borch-Johnsen, K., Lauritzen, T., & Sandbæk, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4323-2 · Cited by 51
“As governments seek to apply the principles of prevention to chronic disease, health check programmes have been proposed or introduced in a number of countries, including the UK and the USA [1, 2].”
BackgroundInfluentialClaypool, K. T., Chung, M. K., Deonarine, A., Gregg, E. W., & Patel, C. J. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000965 · Cited by 56
Random plasma glucose predicts the diagnosis of diabetes
Rhee, M. K., Ho, Y.-L. A., Raghavan, S., Vassy, J. L., Cho, K., GAGNON, D. R., Staimez, L. R., Ford, C. N., Wilson, P. W. F., & Phillips, L. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219964 · Cited by 56
“Systematic screening could permit detection earlier in the natural history [6], when use of lifestyle change strategies and/or medications could help prevent or delay progression from prediabetes to diabetes [7], and the development of diabetes complications [8].”
BackgroundPredictive models for conversion of prediabetes to diabetes
Yokota, N., Miyakoshi, T., Sato, Y., Nakasone, Y., Yamashita, K., Imai, T., Hirabayashi, K., Koike, H., Yamauchi, K., & Aizawa, T. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.005 · Cited by 54
Scirica, B. M. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.255539 · Cited by 55
The Current State of Traumatic Brain Injury Biomarker Measurement Methods
Krausz, A. D., Korley, F. K., & Burns, M. A. (2021) · Biosensors · doi:10.3390/bios11090319 · Cited by 59
“A diagnostic marker can be used to detect the presence of a disease or condition of interest such as blood sugar or hemoglobin A1c in Type 2 diabetes mellitus [14].”
MethodKandula, N. R., Moran, M. R., Tang, J. W., & O’Brien, M. J. (2017) · Clinical Diabetes · doi:10.2337/cd17-0049 · Cited by 47
Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study
Liu, N., Birstler, J., Venkatesh, M., Hanrahan, L. P., Chen, G., & Funk, L. M. (2021) · Journal of Medical Internet Research · doi:10.2196/24017 · Cited by 44
“For example, the United States Preventative Services Task Force (USPSTF) recommends screening for T2DM [26] and hypertension [27] at a BMI cut point of 25 kg/m 2 .”
Shortt, C. R., Ma, J., Clayton, N., Sherbino, J., Whitlock, R. P., Paré, G., Hill, S., McQueen, M., Mehta, S. R., Devereaux, P. J., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.261545 · Cited by 41
Emirates Diabetes Society Consensus Guidelines for the Management of Type 2 Diabetes Mellitus – 2020
Alawadi, F., Abusnana, S., Afandi, B. O., Aldahmani, K. M., Hajeri, O. M. A., Aljaberi, K., Alkaabi, J., Al-Madani, A., Bashier, A. M., Beshyah, S., et al. (2020) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000506508 · Cited by 47
Undiagnosed Diabetes Mellitus in Community-Acquired Pneumonia: A Prospective Cohort Study
Jensen, A. V., Faurholt‐Jepsen, D., Egelund, G. B., Andersen, S. B., Petersen, P. T., Benfield, T., Witzenrath, M., Rohde, G. G. U., Ravn, P., for the German Community-Acquired Pneumonia Competence Network (CAPNETZ), et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix703 · Cited by 41
Metabolically Healthy Obesity and Risk of Kidney Function Decline
Chang, A. R., Surapaneni, A., Kirchner, H. L., Young, A. J., Kramer, H., Carey, D. J., Appel, L. J., & Grams, M. E. (2018) · Obesity · doi:10.1002/oby.22134 · Cited by 41
Greenberg, J., Zwiep, T., Sadek, J. R., Malcolm, J., Mullen, K. A., McIsaac, D. I., Musselman, R., & Moloo, H. (2021) · Canadian Journal of Surgery · doi:10.1503/cjs.011519 · Cited by 45
Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study
McKenzie, A. L., Athinarayanan, S. J., McCue, J. J., Adams, R. N., Keyes, M., McCarter, J. P., Volek, J. S., Phinney, S. D., & Hallberg, S. J. (2021) · Nutrients · doi:10.3390/nu13030749 · Cited by 37
Type 2 diabetes detection and management among insured adults
Dall, T. M., Yang, W., Halder, P., Franz, J., Byrne, E. N., Semilla, A. P., Chakrabarti, R., & Stuart, B. (2016) · Population Health Metrics · doi:10.1186/s12963-016-0110-4 · Cited by 39
“The new guidelines from the US Preventive Services Task Force for diabetes screening of asymptomatic adults recommend screening for adults with risk factors for diabetes (including all adults aged 40 to 70 years who are overweight or obese, or who have one or more other known risk factors for diabetes such as family h…”
BackgroundJonas, D. E., Ferrari, R. M., Wines, R., Vuong, K. T., Cotter, A., & Harris, R. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.08.033 · Cited by 53
An assessment of medical students’ knowledge of prediabetes and diabetes prevention
Khan, T., Wozniak, G., & Kirley, K. (2019) · BMC Medical Education · doi:10.1186/s12909-019-1721-9 · Cited by 41
Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans
Sharma, A. R., Varghese, R. T., Shah, M., Man, C. D., Cobelli, C., Rizza, R. A., Bailey, K. R., & Vella, A. V. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01197 · Cited by 38
Alzubaidi, H., Chandir, S., Hasan, S., Namara, K. M., Cox, R., & Krass, I. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031246 · Cited by 35
Chung, I., Rajakumar, G., Subramanian, U., Venkidasamy, B., Khanna, V. G., & Thiruvengadam, M. (2019) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1853 · Cited by 34
Clinical Identification and Referral of Adults With Prediabetes to a Diabetes Prevention Program
Holliday, C. S., Williams, J., Salcedo, V., & Kandula, N. R. (2019) · Preventing Chronic Disease · doi:10.5888/pcd16.180540 · Cited by 32
O’Brien, M. J., Lee, J. Y., Carnethon, M. R., Ackermann, R. T., Vargas, M. C., Hamilton, A., Mohanty, N., Rittner, S. S., Park, J. N., Hassan, A., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002074 · Cited by 36
“We chose this duration of follow-up because it is the recommended time interval for dysglycemia screening [14].”
MethodInfluentialWhitley, H. P., Hanson, C., & Parton, J. (2017) · The Annals of Family Medicine · doi:10.1370/afm.2035 · Cited by 31
Park, S. K., Ryoo, J., Oh, C., Choi, J., & Jung, J. Y. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0868 · Cited by 34
Tang, O., Foti, K., Miller, E. R., Appel, L. J., & Juraschek, S. P. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa093 · Cited by 30
Diabetes in Normal-Weight Individuals: High Susceptibility in Nonwhite Populations
Gujral, U. P., & Narayan, K. M. V. (2019) · Diabetes Care · doi:10.2337/dci19-0046 · Cited by 30
DiBenedetto, J. C., Blum, N. M., O’Brian, C. A., Kolb, L. E., & Lipman, R. D. (2016) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716668415 · Cited by 32
“Although the previous recommendation was for screening for abnormal blood glucose in asymptomatic adults with sustained blood pressure >135/80 mm Hg (treated or untreated),(2) the current update broadens the category of adults to be screened to those at “increased risk,” defined as having factors that raise the chance…”
BackgroundAckermann, R. T. (2017) · Diabetes Care · doi:10.2337/dci17-0012 · Cited by 28
Screening for Prediabetes and Type 2 Diabetes Mellitus
Laiteerapong, N., & Cifu, A. S. (2016) · JAMA · doi:10.1001/jama.2015.17545 · Cited by 27
Glucose challenge test screening for prediabetes and early diabetes
Jackson, S. L., Safo, S. E., Staimez, L. R., Olson, D. E., Narayan, K. M. V., Long, Q., Lipscomb, J., Rhee, M. K., Wilson, P. W. F., Tomolo, A. M., et al. (2016) · Diabetic Medicine · doi:10.1111/dme.13270 · Cited by 27
“US Preventive Services Task Force has created recommendations for systematic screening [5].”
Performance of a Random Glucose Case-Finding Strategy to Detect Undiagnosed Diabetes
Bowen, M. E., Xuan, L., Lingvay, I., & Halm, E. A. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.01.023 · Cited by 29
Bibbins-Domingo, K. B., Whitlock, E. P., Wolff, T., Ngo‐Metzger, Q., Phillips, W. R., Davidson, K. W., Krist, A. H., Lin, J. S., Mangione, C. M., Kurth, A., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2656 · Cited by 27
Self-citationPatterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US
Shealy, K. M., Wu, J., Waites, J., Taylor, N. A., & Sarbacker, G. B. (2019) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2019.02.180259 · Cited by 24
Management of type 2 diabetes: consensus of diabetes organizations
Quattrocchi, E. J., Goldberg, T., & Marzella, N. (2020) · Drugs in Context · doi:10.7573/dic.212607 · Cited by 36
Khanal, S. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/25021.9970 · Cited by 25
Buccheri, E., Dell'Aquila, D., & Russo, M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108722 · Cited by 24
Screening for Prediabetes and Diabetes: Clinical Performance and Implications for Health Equity
O’Brien, M. J., Zhang, Y., Bailey, S. C., Khan, S. S., Ackermann, R. T., Ali, M. K., Benoit, S. R., Imperatore, G., Holliday, C. S., & Bullard, K. M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.01.007 · Cited by 23
Yatsuya, H., Li, Y., Hirakawa, Y., Ota, A., Matsunaga, M., Hilawe, E. H., Chiang, C., Zhang, Y., Tamakoshi, K., Toyoshima, H., et al. (2018) · Journal of Epidemiology · doi:10.2188/jea.je20170048 · Cited by 28
Glurich, I., Bartkowiak, B., Berg, R. L., & Acharya, A. (2018) · International Dental Journal · doi:10.1111/idj.12405 · Cited by 26
Diagnosis and management of hidradenitis suppurativa in women
Collier, E. K., Parvataneni, R., Lowes, M. A., Naik, H. B., Okun, M. M., Shi, V. Y., & Hsiao, J. L. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.09.036 · Cited by 23
Dong, W., Tse, E. T. Y., Mak, I. L., Wong, C. K. H., Wan, E. Y. F., Tang, E. H. M., Chin, W. Y., Bedford, L. E., Yu, E. Y. T., Ko, W. K. W., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13790 · Cited by 26
Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults
Bowen, M. E., Schmittdiel, J. A., Kullgren, J. T., Ackermann, R. T., & O’Brien, M. J. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1090-5 · Cited by 23
Cheng, H., Jia, Z., Li, Y., Yu, X., Wang, J. J., Xie, Y. J., Hernández, J., & Wang, H. (2024) · JMIR Public Health and Surveillance · doi:10.2196/49617 · Cited by 28
“Evidence suggests that the progression of T2DM and its complications can largely be delayed through population-based early preventive public health programs [10,11].”
BackgroundSitnik, D., Santos, I. S., Goulart, A. C., Staniak, H. L., Manson, J. E., Lotufo, P. A., & Benseñor, I. M. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116653356 · Cited by 21
Wells, B. J., Lenoir, K. M., Diaz‐Garelli, F., Futrell, W. M., Lockerman, E., Pantalone, K. M., & Kattan, M. W. (2018) · JMIR Medical Informatics · doi:10.2196/10780 · Cited by 24
“The USPSTF acknowledges that patients with other high-risk characteristics (eg, family history of diabetes, personal history of gestational diabetes) may need to be screened sooner but this is left up to the physician’s discretion [23].”
Metadata
- Authors
- Siu, A. L., & on behalf of the U.S. Preventive Services Task Force*
- Affiliations
- United States Preventive Services Task Force (US)
- Corresponding author
- Siu, Albert L.
- ORCID
- Siu, Albert L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-12-01
- Volume
- 163
- Issue
- 11
- Pages
- 861-868
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2184512969
- Semantic Scholar
- d2283e77e36b23e882188941e6140255c0dc9669
- Cited by
- 319
- References
- 49
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 16 · 2023: 30 · 2022: 16 · 2021: 56 · 2020: 40 · 2019: 27 · 2018: 39 · 2017: 42 · 2016: 32 · 2015: 1
- FWCI
- 40.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, diabetes screening, impaired fasting glucose, impaired glucose tolerance, abnormal blood glucose, asymptomatic adults, overweight and obesity, cardiovascular risk assessment, behavioral counseling, primary care
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Mass Screening, Middle Aged, Cost of Illness, Risk Assessment, Glucose Metabolism Disorders, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.